A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer
View abstract on PubMed
Summary
This summary is machine-generated.Adding letrozole therapy after standard tamoxifen treatment significantly improves disease-free survival in postmenopausal women with breast cancer. This extended treatment shows promising results for preventing cancer recurrence.
Area Of Science
- Oncology
- Endocrinology
Background
- Five years of tamoxifen therapy improves survival in hormone-dependent breast cancer but longer durations do not.
- Aromatase inhibitors like letrozole may enhance outcomes post-tamoxifen by suppressing estrogen.
Purpose Of The Study
- To evaluate the efficacy of five years of letrozole therapy in postmenopausal women after completing five years of tamoxifen for breast cancer.
Main Methods
- A double-blind, placebo-controlled trial was conducted.
- The primary endpoint was disease-free survival.
- 5187 postmenopausal women were enrolled with a median follow-up of 2.4 years.
Main Results
- Letrozole significantly improved disease-free survival (93% vs. 87% at 4 years, P<0.001).
- Fewer recurrences or new primary cancers were observed in the letrozole group (75 vs. 132).
- Overall survival did not differ significantly (P=0.25); however, hot flashes and arthralgia were more frequent with letrozole.
Conclusions
- Letrozole therapy following standard tamoxifen treatment significantly enhances disease-free survival.
- The trial was terminated early due to the clear benefit observed in the letrozole arm.
Related Concept Videos
Overview
Vaccination is the administration of antigenic material from pathogens to confer immunity against a specific microorganism. Vaccination primes the immune system to recognize and mount an immune response faster and more effectively if the real pathogen is encountered. Vaccinations are one of the most efficient ways to protect both individual humans and the general public from disease. A growing anti-vaccination skepticism risks the successes of vaccination programs that helped reduce...
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

